
Eastman Chemical Company (NYSE:EMN – Free Report) – Equities researchers at Zacks Research cut their Q1 2028 earnings per share estimates for shares of Eastman Chemical in a research note issued to investors on Wednesday, May 13th. Zacks Research analyst Team now expects that the basic materials company will post earnings of $1.54 per share for the quarter, down from their previous estimate of $1.68. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Eastman Chemical’s current full-year earnings is $6.33 per share. Zacks Research also issued estimates for Eastman Chemical’s FY2028 earnings at $7.09 EPS.
Eastman Chemical (NYSE:EMN – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The basic materials company reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.02. Eastman Chemical had a net margin of 4.62% and a return on equity of 8.88%. The company had revenue of $2.18 billion during the quarter, compared to analysts’ expectations of $2.17 billion. During the same period last year, the business earned $1.91 EPS. The business’s quarterly revenue was down 4.9% on a year-over-year basis. Eastman Chemical has set its Q2 2026 guidance at 1.700-1.900 EPS.
Get Our Latest Report on Eastman Chemical
Eastman Chemical Stock Performance
Shares of EMN opened at $72.57 on Friday. The stock has a market capitalization of $8.30 billion, a price-to-earnings ratio of 21.04, a PEG ratio of 0.94 and a beta of 1.04. Eastman Chemical has a 12 month low of $56.11 and a 12 month high of $83.47. The firm has a fifty day simple moving average of $72.33 and a 200 day simple moving average of $68.84. The company has a current ratio of 1.47, a quick ratio of 0.71 and a debt-to-equity ratio of 0.73.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the stock. MUFG Securities EMEA plc bought a new stake in shares of Eastman Chemical during the 2nd quarter worth approximately $25,000. Altshuler Shaham Ltd bought a new position in Eastman Chemical in the fourth quarter valued at about $25,000. Brown Lisle Cummings Inc. boosted its stake in shares of Eastman Chemical by 70.0% during the fourth quarter. Brown Lisle Cummings Inc. now owns 425 shares of the basic materials company’s stock valued at $27,000 after purchasing an additional 175 shares in the last quarter. Garton & Associates Financial Advisors LLC bought a new stake in shares of Eastman Chemical during the fourth quarter worth about $27,000. Finally, Los Angeles Capital Management LLC acquired a new position in shares of Eastman Chemical in the fourth quarter valued at approximately $27,000. Institutional investors own 83.65% of the company’s stock.
Eastman Chemical Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 8th. Stockholders of record on Monday, June 15th will be given a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a dividend yield of 4.6%. The ex-dividend date is Monday, June 15th. Eastman Chemical’s payout ratio is presently 97.39%.
Eastman Chemical Company Profile
Eastman Chemical Company (NYSE: EMN) is a global specialty materials company that develops, manufactures and markets a broad range of advanced materials, chemicals and fibers. Its product portfolio spans performance additives, functional products, and engineered plastics designed to enhance the durability, appearance and performance of end products across diverse industries.
The company’s main business activities include the production of specialty chemicals used in adhesives, coatings, building materials and consumer care applications, as well as high-performance plastics for packaging, automotive and electronics markets.
Read More
- Five stocks we like better than Eastman Chemical
- Karman: Defense Darling’s Outlook Strengthens After 40% Drop
- Aeluma’s Post-Earnings Dip Creates a Buying Opportunity
- Be Ready: 3 Upcoming Catalysts Could Drive Oracle to Record Highs
- 2 Ways to Play the Big Pharma Patent Cliff
Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.
